Shuangshuang Mao

6PUBLICATIONS
2CO-AUTHORS
Molecular targetsMedical microbiology not elsewhere classifiedPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 21, 2022
Crosstalk of Eight Types of RNA Modification Regulators Defines Tumor Microenvironments, Cancer Hallmarks, and Prognosis of Lung Adenocarcinoma.

Shuangshuang Mao, Zuhua Chen, Yingying Wu

|Oct 31, 2020
The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer.

Yuanyuan Lei, Zhiliang Lu, Jianbing Huang

|Oct 15, 2020
ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells.

Yuanyuan Lei, Ruochuan Zang, Zhiliang Lu

|Mar 19, 2020
Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state.

Jianbing Huang, Jiagen Li, Sufei Zheng

|Mar 14, 2020
Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial.

Nan Sun, Shouguo Sun, Yibo Gao

|Jul 11, 2018
Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.

Yun Che, Jingnan Wang, Yuan Li

Pageof 1

Frequent Collaborators

4 joint publications

Jie He

1 joint publications

Xianglin Yuan